ProArc Medical

Company Overview

Snapshot

Founded in July 2010 by Yair Feld, ProArc Medical operates with 1–10 employees. The company has raised a total of $2.28M across four funding rounds from two investors. In July 2019, ProArc Medical was awarded a $2.2 million grant from the European Union.

Business overview

ProArc Medical is a medical device company focused on developing and commercializing noninvasive solutions for benign prostatic hyperplasia (BPH), also known as enlarged prostate. Its core product, ClearRing, is a prostatic reshaping device designed to treat lower urinary tract symptoms associated with BPH. The device utilizes a nitinol implant in an open ring shape, placed in the enlarged prostate tissue to expand the obstructed area without long-term contact with urine. The single-operator device is compatible with standard cystoscopes, facilitating convenient use by physicians. ProArc Medical operates within the Health Tech & Life Sciences sector, specifically targeting the medical devices and medical treatment & therapeutics industries, serving healthcare providers.

Strategic signal

In July 2019, ProArc Medical secured a significant $2.2 million grant from the European Union. This non-dilutive funding provides substantial validation for the company's ClearRing device and its potential in the urology market, signaling strong European interest and support for its innovative approach to treating benign prostatic hyperplasia.

Company Intelligence Q&A

What is ProArc Medical's primary focus?

ProArc Medical is dedicated to developing and commercializing noninvasive medical devices for the treatment of benign prostatic hyperplasia (BPH), or enlarged prostate.

What is the ClearRing device?

The ClearRing device is ProArc Medical's prostatic reshaping device, designed to treat lower urinary tract symptoms resulting from BPH. It consists of a nitinol implant in the shape of an open ring, placed in the enlarged prostate tissue.

When was ProArc Medical founded and by whom?

ProArc Medical was founded in July 2010 by Yair Feld.

Has ProArc Medical received any significant grants?

Yes, in July 2019, ProArc Medical was awarded a $2.2 million grant from the European Union. Additionally, in January 2018, the company received a grant from the Israel Innovation Authority.

Which investor participated in ProArc Medical's January 2021 funding round?

In January 2021, ExitValley led an equity crowdfunding round for ProArc Medical.